Promethazine

sedating antihistamine

Promethazine, dem sell under de brand name Phenergan among odas, be a first-generation antihistamine, sedative, den antiemetic dem use to treat allergies, nausea, den vomiting. E sanso fi help plus sam symptoms dem associate plus de common cold[1] den sanso fi be used for sedating people wey be agitated anaa anxious, an effect wey lead to sam recreational use (especially plus codeine).[2][3][4] Dem dey take promethazine by mouth (oral), as a rectal suppository, anaa by injection into a muscle (IM).[1]

(±)-promethazine
group of stereoisomers, type of chemical entity
Subclass ofphenothiazine, Medication Edit
Native labelPromethazine Edit
Chemical formulaC₁₇H₂₀N₂S Edit
Canonical SMILESCC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C Edit
Active ingredient inPhenergan, Phenadoz, Promethegan Edit
World Health Organisation international non-proprietary namepromethazine Edit
Medical condition treatedvomiting, motion sickness, postoperative complications, pain Edit
Physically dey interact plusHistamine receptor H1 Edit
Pregnancy categoryAustralian pregnancy category C, US pregnancy category C Edit
LiverTox likelihood scoreLiverTox toxicity likelihood category E Edit
Subject has roleantipruritic, dopamine antagonist, H1 antagonist, anti-allergic agents Edit
MCN code2934.30.30 Edit

Common side effects of promethazine dey include confusion den sleepiness;[1] consumption of alcohol anaa oda sedatives fi make dese symptoms worse.[1] E be unclear if use of promethazine during pregnancy anaa breastfeeding be safe.[1][5] Use of promethazine no be recommended insyd those less dan two years old, secof potentially negative effects on breathing.[1] Use of promethazine by injection into a vein no be recommended, secof potential skin damage.[1] Promethazine dey insyd de phenothiazine family of medications.[1] E sanso be a strong anticholinergic den at high anaa toxic doses fi act as a deliriant.[6]

Dem make promethazine insyd de 1940s by a team of scientists wey komot Rhône-Poulenc laboratories.[7] Na e be approved for medical use insyd de United States insyd 1951.[1] E be a generic medication wey be available under chaw brand names globally.[8] Insyd 2023, na e be de 230th most commonly prescribed medication insyd de United States, plus more dan 1 million prescriptions;[9][10] den de combination plus dextromethorphan be de 252nd most commonly prescribed medication insyd de United States, plus more dan 1 million prescriptions.[11][12]

Pharmacology

edit

Anoda notable use of promethazine be as a local anesthetic, by blockage of sodium channels.[13]

Binding to receptors in nM (Ki)
receptor Ki (nM) ref
α1A-adrenoceptor (Rat) 32 [14]
α1B-adrenoceptor (Rat) 21 [14]
α1D-adrenoceptor (Human) 90 [14]
α2A-adrenoceptor (Human) 256 [14]
α2B-adrenoceptor (Human) 24 [14]
α2C-adrenoceptor (Human) 353 [14]
Calmodulin (Human) 60000 [15][14][16]
Calmodulin (Bovine) 50000 [15][16][14]
Chloroquine resistance transporter (Plasmodium falciparum) 85000 [17][14]
D1 receptor (Human) 1372 [14]
D2 receptor (Human) 260 [14]
D3 receptor (Human) 190 [14]
H1 receptor (Human) 0.33[14]-1.4[18] [18][14]
H2 receptor (Human) 1146 [14]
M1 receptor (Human) 3.32 [14]
M2 receptor (Human) 12 [14]
M3 receptor (Human) 4.15 [14]
M4 receptor (Human) 1.06 [14]
M5 receptor (Human) 3.31 [14]
NET (Norephinephrine transporter) (Human) 4203 [14]
Prion protein (Human) 8000 [19][14]
5-HT1A receptor (Rat) 1484 [14]
5-HT2A receptor (Human) 19 [14]
5-HT2B receptor (Human) 43 [14]
5-HT2C receptor (Human) 6.48 [14]
5-HT6 receptor (Human) 1128 [14]
SERT (Serotonin transporter) (Human) 2130 [14]
Sigma1 receptor (Human) 120 [14]
OCT1 (Human) 35100 [20][14]

References

edit
  1. 1 2 3 4 5 6 7 8 9 "Promethazine Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 24 October 2018.
  2. Agnich LE, Stogner JM, Miller BL, Marcum CD (September 2013). "Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures" (PDF). Addictive Behaviors. 38 (9): 2445–9. doi:10.1016/j.addbeh.2013.03.020. PMID 23688907.
  3. British national formulary: BNF 74 (74 ed.). British Medical Association. 2017. p. 276. ISBN 978-0-85711-298-9.
  4. Malamed SF (2009). Sedation: A Guide to Patient Management (in English). Elsevier Health Sciences. p. 113. ISBN 978-0-323-07596-1.
  5. British national formulary: BNF 74 (74 ed.). British Medical Association. 2017. p. 276. ISBN 978-0-85711-298-9.
  6. Page CB, Duffull SB, Whyte IM, Isbister GK (February 2009). "Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal". QJM. 102 (2): 123–131. doi:10.1093/qjmed/hcn153. PMID 19042969. S2CID 17677540.
  7. Li JJ (2006). Laughing Gas, Viagra, and Lipitor: The Human Stories behind the Drugs We Use. United Kingdom: Oxford University Press. p. 146. ISBN 978-0-19-988528-2. Retrieved 9 July 2016.
  8. "Promethazine international brands". Drugs.com. Retrieved 17 July 2017.
  9. "The Top 300 of 2023". ClinCalc. Archived from the original on 17 August 2025. Retrieved 17 August 2025.
  10. "Promethazine Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 17 August 2025.
  11. "The Top 300 of 2023". ClinCalc. Archived from the original on 17 August 2025. Retrieved 17 August 2025.
  12. "Dextromethorphan; Promethazine Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 17 August 2025.
  13. Prasad JP (2010). Conceptual Pharmacology. Universities Press. pp. 295, 303, 598. ISBN 978-81-7371-679-9. Retrieved 27 November 2011.
  14. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 "promethazine | Ligand Activity Charts | IUPHAR/BPS Guide to PHARMACOLOGY". www.guidetopharmacology.org (in English). Retrieved 18 May 2023.
  15. 1 2 Bruno C, Cavalluzzi MM, Rusciano MR, Lovece A, Carrieri A, Pracella R, Giannuzzi G, Polimeno L, Viale M, Illario M, Franchini C, Lentini G (June 2016). "The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca(2+)/calmodulin-dependent kinase II". European Journal of Medicinal Chemistry. 116: 36–45. doi:10.1016/j.ejmech.2016.03.045. PMID 27043269.
  16. 1 2 Bolshan Y, Getlik M, Kuznetsova E, Wasney GA, Hajian T, Poda G, Nguyen KT, Wu H, Dombrovski L, Dong A, Senisterra G, Schapira M, Arrowsmith CH, Brown PJ, Al-Awar R, Vedadi M, Smil D (March 2013). "Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction". ACS Medicinal Chemistry Letters. 4 (3): 353–357. doi:10.1021/ml300467n. PMC 4027439. PMID 24900672.
  17. Deane KJ, Summers RL, Lehane AM, Martin RE, Barrow RA (May 2014). "Chlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT". ACS Medicinal Chemistry Letters. 5 (5): 576–581. doi:10.1021/ml5000228. PMC 4027738. PMID 24900883.
  18. 1 2 Nakai T, Kitamura N, Hashimoto T, Kajimoto Y, Nishino N, Mita T, Tanaka C (August 1991). "Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia". Biological Psychiatry. 30 (4): 349–356. doi:10.1016/0006-3223(91)90290-3. PMID 1912125. S2CID 9715772.
  19. Vogtherr M, Grimme S, Elshorst B, Jacobs DM, Fiebig K, Griesinger C, Zahn R (August 2003). "Antimalarial drug quinacrine binds to C-terminal helix of cellular prion protein". Journal of Medicinal Chemistry. 46 (17): 3563–3564. doi:10.1021/jm034093h. PMID 12904059.
  20. Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P (October 2008). "Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1". Journal of Medicinal Chemistry. 51 (19): 5932–5942. doi:10.1021/jm8003152. PMID 18788725.
edit